A reevaluation of the clinical characteristics of clozapine-induced agranulocytosis in light of the United States experience

J Clin Psychopharmacol. 1994 Apr;14(2):87-9.

Authors

J M Alvir, J A Lieberman

PMID: 8195462

No abstract available

Publication types

Editorial

MeSH terms

Agranulocytosis / chemically induced*
Agranulocytosis / prevention & control*
Clozapine / adverse effects*
Humans
Incidence
Leukocyte Count / economics
Risk Factors
United States

Substances

Clozapine